Bill > HR6626

This bill, the PFAS Accountability Act of 2025, amends the Toxic Substances Control Act to establish a federal legal pathway for individuals significantly exposed to per- and polyfluoroalkyl substances (PFAS), a group of man-made chemicals found in many consumer products and increasingly detected in drinking water and human blood. The bill creates a cause of action, allowing individuals to sue entities responsible for manufacturing or using PFAS if they knew or should have known their actions would lead to human exposure. Crucially, it also allows for a medical monitoring remedy, meaning courts can order responsible parties to pay for regular health check-ups for those exposed to PFAS if there's an increased risk of developing related diseases, and it provides a presumption of significant exposure if certain conditions are met, such as release of PFAS into areas where exposure occurred or detection of PFAS in the body. The bill aims to shift the costs of medical monitoring from individuals to those responsible for the exposure and encourages industry to fund research into PFAS safety, while explicitly stating it does not prevent individuals from pursuing claims under state law.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/6626/all-info